AzTrials
AzTrials

AnxietyNCT06155838

Reducing Depression and Anxiety Among Teens

A study testing "Early Adolescent Skills for Emotions (EASE) in people with Anxiety and Depression, run by Aga Khan University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this clinical trial is to assess the efficacy of the Early Adolescent Skills for Emotions (EASE) program, a school-based, non-specialist psychosocial intervention developed by the WHO for LMICs, in alleviating Anxiety and Depression among teens aged 13-19. Read more about this study

Who is it for?
Ages 13 to 19 yearsHealthy volunteers can take part
Conditions the study is for
Anxiety, Depression
What is being tested?
"Early Adolescent Skills for Emotions (EASE)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
450 participants
Where
1 sitePakistan
Study dates
27 Nov 2023to 31 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 19 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Teens aged 13-19 years
  • Living with parents/primary caregivers
  • Enrolled in public middle and high schools of Multan, Southern Punjab, Pakistan
  • Teens Assent - agreed and signed by teen
  • Informed consent from parents- agreed and signed by parents

Who cannot join

  • Teens part of a dysfunctional family
  • Psychiatric issues
  • Physical and sensory disorder diagnosis.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Office of the Chief Executive Officer, District Education Authority, Multan

    Multan Khurd, Punjab Province

Other trials in Pakistan

About this study

Official title: Reducing Depression and Anxiety Among Teens in Multan, Pakistan: a Cluster Randomized Controlled Trial

The objective of this clinical trial is to assess the efficacy of the Early Adolescent Skills for Emotions (EASE) program, a school-based, non-specialist psychosocial intervention developed by the WHO for LMICs, in alleviating Anxiety and Depression among teens aged 13-19. The primary inquiries it seeks to address include:

Does the EASE intervention effectively reduce anxiety and depression scores 12 weeks after implementation?

  • Can the EASE intervention enhance quality of life, improve problem-solving skills, and increase perceived emotional support?
  • Is the EASE intervention beneficial for enhancing the psychological well-being of parents and fostering positive parent-teen relationships?
Read the detailed description

Background:

Anxiety and depression significantly impact global adolescent mental health, with 1 in 4 adolescents requiring immediate attention. Many mental health disorders emerge in late childhood and early adolescence, worsening the burden on youth and later in life. In severe cases, suicide can occur at an alarming rate of one person every 40 seconds. In Pakistan, with a large population of 220 million, 50% aged between 12-25, the rates of anxiety and depression among adolescents are concerning. A recent study of 400 high school adolescents (15-18 years) in Pakistan revealed a prevalence of around 53% for anxiety and depression. Early preventive interventions like cognitive behaviour therapy and interpersonal therapy can empower adolescents to manage these issues, but accessing mental health services conveniently remains a challenge. Engaging mainstream academic institutions for early intervention in schools is crucial to combat anxiety, depression, and suicidal thoughts among adolescents in Pakistan.

Introduction:

Anxiety and depression pose significant psychological distress and mental health challenges for adolescents worldwide, highlighting the need for evidence-based psychological interventions tailored to teens. This study aims to assess the effectiveness of a school-based psychosocial intervention, the Early Adolescent Skills for Emotions (EASE) program developed by the WHO, in reducing psychosocial distress among adolescents aged 13-19.

Method and Analysis:

A two-parallel-arm, single-blinded, cluster randomized controlled trial will be conducted in Multan, Pakistan's school settings. Eight eligible public school clusters will be randomly allocated in a 1:1 ratio to the control arm (n=4) and intervention arm (n=4). The trial will recruit 450 adolescents (56 students from each school) experiencing psychosocial distress between April and May 2023. In the intervention arm, teens will receive the EASE program over 7 weeks, featuring psychoeducation, stress management, behavioural activation, problem-solving, and relapse prevention. Teachers will be trained in active listening, quality time spent, and the use of praise to assist their students. A qualitative study will explore facilitating and challenging factors related to intervention in low-resource school settings.

Ethical Approval:

Ethical approval has been obtained from the Ethics Committee of the School of Nursing at Shandong University, Jinan, China.

Conditions
Anxiety, Depression
Being tested
"Early Adolescent Skills for Emotions (EASE)
Medical subject headings
Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • "Early Adolescent Skills for Emotions (EASE)Other

    Weekly Schedule for Teen's and their parents Sessions:

    Over the course of 7 sessions, with one session per week lasting 90 minutes, the following core components will be covered:

    Week 1: Exploring My Feelings

    Week 2: Learning to Calm

    Week 3 \& 4: Learning CBT- Restructuring My Thinking, Changing Feelings and My Actions \& Managing My Emotions and Issues

    Week 5 \& 6: Fostering Independent Problem-Solving Skills and Seeking Help

    Week 7: Relapse Prevention

    2.0 For parents/ guardians

    Week 3 Psychoeducation (to develop skills to be able to identify, listen, better respond and provide comfort to teens when they are overwhelmed by anxiety and depression).

    Week 4 Positive parenting strategies

    Week 5 Parents/ guardians Self-care

Study groups in NCT06155838
Study groupRoleWhat they receive
EASE InterventionExperimentalThe intervention consists of four fundamental themes that have empirical support, structured across seven group sessions for adolescents and three group sessions for their parents or guardians. The sessions for teenagers will be conducted in person, spanning seven weeks with one session per week, each lasting 90 minutes. Similarly, three sessions are scheduled for parents. In accordance with WHO guidelines (2016), the intervention will be administered by non-specialist co-facilitators(class teachers) who possess at least 16 years of education (undergraduate degree). These co-facilitators will undergo a ten-day training program, demonstrating mock sessions as part of this training. During the intervention delivery, they will also benefit from weekly supervision provided by a specialist, who will be a graduate psychologist or trained nurse in mental health.
Receives: Other: "Early Adolescent Skills for Emotions (EASE)
control/ wait listNo interventionThroughout the study, participants in the control group will continue to receive standard treatment. Nevertheless, following the conclusion of the trial, all control group participants will undergo the EASE intervention over a seven-week period, which will also involve three sessions for their parents and guardians. This approach ensures that the control group is not placed at a disadvantage, in alignment with ethical principles.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Aga Khan University Anxiety and Depression Scale (AKUADS-25)

    AKUADS will be used to assess anxiety and depression affecting the target population. Items score ranges from 0-3 (0= never, 1=sometime, 2=mostly, 3=always) for each question item hence the total score of the tool is 0-75. The higher the score the more anxiety and depression will be severe with the cut score of 19.

    Measured: at 12 weeks' post-intervention

Secondary outcomes (8)
  1. The Kessler Psychological Distress Scale -10 (K-10)

    K-10 will assess psychological distress among teens and parents. It will be measured on a scale from five to one (5=all of the time; 4= Most of the time; 3 some of the time; 2= A little of the time; 1= none of the time). The scores range from 6 to 30, by summing the individual items, total scores are calculated. The higher scores indicate high psychological distress.

    Measured: at 12 weeks' post-intervention

  2. The Perceived Emotional/Personal Support Scale ( PEPSS)

    The Perceived Emotional/Personal Support Scale ( PEPSS) measures the perceived emotional support. On a four-point scale - hardly at all 4 to very much 1. The higher scores show a lack of perceived support.

    Measured: at 12 weeks' post- intervention

  3. The Social Problem-Solving Inventory-Revised Short Form- 25

    it measures problem-solving skills in a situation. The total score of this scale varies between 0 and 20 points. The highest scores correspond to better social problem-solving abilities.

    Measured: at 12 weeks' post- intervention

  4. Parent-rated Pediatric Quality of Life (PedsQL).

    This tool will be utilized to assess the child's quality of life (health-related). This tool measures a child's quality of health on a points Likert scale ranging from 'no problem= 1' to 'almost always a problem= 4'. "Items are then reverse-scored and linearly transformed to a 0-100 so that higher scores indicate better quality of life.

    Measured: at 12 weeks' post- intervention

  5. Parenting practices

    The assessment of parenting behaviors and practices will utilize the Alabama Parenting Questionnaire-42 (APQ-42) (Maguin, Nochajski, De Wit, \& Safyer, 2016)., this tool includes five constructs : involvement (10 items), supervision and monitoring (10 items), positive parenting (6 items), consistent discipline (6 items), and corporal punishment (3 items), with the additional 7 items addressing alternative disciplinary practices. Each item, rated on a 5-point scale from 1 (never) to 5 (always), contributes to the construct's score, calculated by summing the relevant items.

    Measured: at 12 weeks' post- intervention

  6. The Psychological Sense of School Membership

    The assessment of perceived belonging and psychological engagement in school will utilize the Psychological Sense of School Membership (PSSM) scale (Goodenow, 1993). This comprehensive scale delves into the sense of belonging in school environments, focusing on caring relationships, acceptance, and rejection. Comprising 18 items rated on a likert scale from 1 (not at all true) to 5 (completely true), scores are calculated by summing responses and then averaging, resulting in a score range of 1 to 5. Higher scores signify a stronger sense of perceived belonging and engagement within the school community.

    Measured: at 12 weeks' post- intervention

  7. Strengths and Difficulty Questionnaire

    The Strengths and Difficulties Questionnaire (SDQ), a widely utilized screening tool for assessing psychological adjustment in children and adolescents (Goodman et al., 1998), categorizes positive attributes (strengths) and problematic behaviors (difficulties) across five domains, each comprising 5 items: emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship problems, and prosocial behavior (strengths). Respondents use a Likert scale ("not true= 0," "somewhat true=1," or "certainly true=2") to indicate their response, representing a three-point categorical scale. Scores within each domain are summed, with higher scores in emotional symptoms, conduct problems, hyperactivity/inattention, and peer relationship problems indicating greater difficulties, while higher scores in the prosocial behavior domain signify strengths.

    Measured: at 12 weeks' post- intervention

  8. Moderating Factors

    We will also explore potential moderating factors that may influence the intervention's effectiveness on the primary outcomes. These factors include gender, age groups, socioeconomic status, parental education, and parents' psychological well-being. Statistical analyses will assess whether these variables moderate the relationship between the intervention and changes in anxiety and depression.

    Measured: T1, T2, T3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2023
  2. Study start27 Nov 2023
  3. Primary completion31 Mar 2024
  4. Study completion31 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
450 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06155838
Sponsor's protocol ID
AgaKhanUGhazalet.al(2023)
Status last verified
Jan 2025
First submitted
17 Apr 2023
Last updated
3 Feb 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: As mentioned below.

Publications

  • Ghazal L, Cui N, Cao F. To evaluate the EASE intervention for reducing anxiety and depression among adolescents in Pakistan: a protocol for a mixed methods study, including a cluster-randomised controlled trial. BMJ Open. 2025 Mar 22;15(3):e086393. doi: 10.1136/bmjopen-2024-086393.

    PubMed 40122537

Questions about this trial

What is this clinical trial studying?

A study testing "Early Adolescent Skills for Emotions (EASE) in people with Anxiety and Depression, run by Aga Khan University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Aga Khan University Anxiety and Depression Scale (AKUADS-25) (time frame: at 12 weeks' post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06155838, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in